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Despite advances in genetic research, causal variants affecting risk for schizophrenia
remain poorly characterized, and the top 108 loci identified through genome-wide
association studies (GWAS) explain only 3.4% of variance in risk profiles. Such work
is defining the highly complex nature of this condition, with omnigenic models of
schizophrenia suggesting that gene regulatory networks are sufficiently interconnected
such that altered expression of any “peripheral” gene in a relevant cell type has the
capacity to indirectly modulate the expression of “core” schizophrenia-associated genes.
This wealth of associated genes with small effect sizes makes identifying new druggable
targets difficult, and current pharmacological treatments for schizophrenia can involve
serious side effects. However, the fact that the majority of schizophrenia genome-
wide associated variants fall within non-coding DNA is suggestive of their potential to
modulate gene regulation. This would be consistent with risks that can be mediated in
a “gene × environment” (G × E) manner. Stress and trauma can alter the regulation
of key brain-related pathways over the lifetime of an individual, including modulation
of brain development, and neurochemistry in the adult. Recent studies demonstrate
a significant overlap between psychotic symptoms and trauma, ranging from prior
trauma contributing to psychosis, as well as trauma in response to the experience
of psychosis itself or in response to treatment. Given the known effects of trauma
on both CNS gene expression and severity of psychosis symptoms, it may be that
pharmacological treatment alone risks leaving individuals with a highly stressful and
unresolved environmental component that continues to act in a “G× E” manner, with the
likelihood that this would negatively impact recovery and relapse risk. This review aims to
cover the recent advances elucidating the complex genetic architecture of schizophrenia,
as well as the long-term effects of early life trauma on brain function and future mental
health risk. Further, the evidence demonstrating the role of ongoing responses to trauma
or heightened stress sensitivity, and their impact on the course of illness and recovery, is
presented. Finally, the need for trauma-informed approaches and psychological therapy-
based interventions is discussed, and a brief overview of the evidence to determine their
utility is presented.
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INTRODUCTION
Early studies aimed at identifying underlying genetic
components in schizophrenia highlighted both rare disruptions
and common variants in a number of candidate genes such as
Disrupted In Schizophrenia 1 (DISC1) (1, 2). These variants
were identified in individuals with a diagnosis of schizophrenia
and other major mental health conditions through pedigree
analysis, though many schizophrenia candidate gene studies
from this era suffered from lack of statistical power and
reproducibility (3). Recent genome-wide association studies
(GWAS) have significantly advanced our understanding of the
genetic architecture of schizophrenia, revealing that risk for
this condition is highly polygenic in nature (4). Comparing
GWAS data on historical candidate gene variants did not provide
supporting evidence for enrichment of GWAS signal at many
of these previously identified loci (3, 5, 6), suggesting that
implicated variants from early studies may not be representative
of risk in the majority of individuals with this condition.
Schizophrenia GWAS studies have since identified 108 highly
associated loci (4), and have provided some support for the utility
of commonly used antipsychotic medications by highlighting
variants at dopamine receptor genes, such as DRD2, to be
associated with schizophrenia (7). However, currently available
antipsychotic treatments can cause serious side effects in a
number of individuals, such as increasing risk for metabolic and
cardiovascular conditions (8–11).
Druggable target analysis of GWAS data has suggested a
potential role for the repurposing of epilepsy medications and
calcium channel blockers as treatment options to be explored (7).
However, a recent omnigenic model of schizophrenia suggested
that all expressed genes in a relevant cell type may have an effect
on risk (12), and as such, the large number of implicated genes
with small effect sizes, and the broad distribution of risk variants
across the genome (13), has hindered the identification of new
druggable targets.
That the large majority of schizophrenia GWAS single
nucleotide polymorphisms (SNPs) fall in non-coding DNA
(4), with enrichment in open chromatin and predicted
transcriptional regulatory elements (12, 14, 15), would suggest
that risk for this condition is likely to be mediated through gene-
environment (G × E) interactions (16). Indeed, while polygenic
risk scores (PRS) have typically been associated with increased
odds for schizophrenia (4), a recent study examining polygenic
risk with or without obstetric complications suggested that risk
may be highly modified by the effect of early life stressors (17).
Evidence supporting the effect of early life stress and trauma
on psychosis risk is robust (18, 19), with an evident dose-
response relationship between cumulative trauma exposure and
increasing odds for experiencing psychosis (18, 20, 21). Similarly,
studies have demonstrated that exposure to specific types of
maltreatment in childhood can increase the odds of experiencing
specific psychotic symptoms (21).
One in three cases of psychosis are predicted to be due to
the effects of childhood trauma (18, 19), with complementary
evidence demonstrating the beneficial and protective epigenetic
effects of positive parental nurturing in early infancy and
childhood (22, 23). As such, early experiences of trauma
are one of the most preventable risk factors for psychosis
and schizophrenia. Individuals with a history of psychosis
or psychosis-like experiences are significantly more likely to
have experienced trauma than those without a history of
such experiences (24–26). Exposure to early trauma has been
suggested to modulate developmental and molecular pathways
such that an individual may become sensitized to future life
stress (27–29). Indeed, high stress sensitivity has been correlated
with increased rates of psychosis-like symptoms in the general
population across 39 countries (30), and with significantly
increased symptom intensity in individuals with first episode
psychosis (FEP) compared to controls (31). In individuals with
experiences of psychosis, exposure to childhood maltreatment
has also been associated with significant increases in emotional
and psychotic reactivity to small daily life stressors in adulthood
(32). Such research would support the hypothesis that early
life stress can predispose individuals to greater stress reactivity
in adulthood, which would modulate risk for experiencing
psychotic symptoms.
In addition to trauma as a risk factor for psychosis, there
is a growing recognition that the experience of psychosis itself,
and the distress associated with treatment methods, can result
in new or further traumatization. Up to 69% of individuals
that have experienced psychosis suffer post-psychosis trauma
symptoms, while up to 39% develop clinical post-traumatic stress
disorder (PTSD) in response to the events of their psychotic
episodes, including distressing treatment-related events such as
involuntary hospitalization (33–37). It is therefore clear that a
significant subset of individuals with psychosis have endured
repeated trauma, and may be re-traumatized during the course
of illness and treatment (38, 39). Such experiences are likely
to negatively impact treatment response and recovery. For
example, individuals with “treatment resistant” schizophrenia
report exposure to significantly higher rates of stressful life events
and childhood trauma than those with medication-responsive
symptoms (40, 41).
Stressful experiences can modulate the regulation of central
nervous system (CNS) genes and genes involved in stress
response (42–44), though preliminary studies have demonstrated
that psychological therapy can normalize epigenetic marks over
key CNS genes (45–47), suggesting that non-pharmaceutical
treatments are also a plausible route to biological intervention
in the context of mental health. Given this information,
research into the provision and utility of psychological therapy
for individuals with psychosis is currently being undertaken.
Trauma-informed psychological interventions have proven safe
and acceptable for use with those experiencing psychosis (48–
50), and have been shown to be effective in reducing post-
psychosis trauma (51). Similarly, Cognitive Behavioral Therapy
(CBT) has been adapted for use with individuals experiencing
psychosis (CBTp) and has proven to be both safe and effective
for use in this population (52, 53), such that national guidelines
in the UK now recommend this as a frontline treatment for
those experiencing psychosis, or those at high risk (54). CBT
for individuals with psychosis has been shown to result in
sustained improvements in positive symptoms (55–58), as well
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as improvements in depression, anxiety, quality of life, and
functional outcomes, which were maintained at follow up (57,
58). Sustainable improvements in both positive and general
psychosis symptoms have also been demonstrated in a trial of
CBTp with individuals whose condition had previously been
classified as medication-resistant (55).
This review aims to provide a brief outline of the genetic
complexity of schizophrenia, the impact of trauma on brain
development, function, and future mental health, and both the
need and evidence base for trauma-informed approaches and
psychological therapy-based interventions.
THE CURRENT LANDSCAPE OF
SCHIZOPHRENIA GENETICS RESEARCH
Insights From Schizophrenia GWAS
The most recent advances in schizophrenia genetic research
have come from large-scale GWAS, which have identified many
common SNPs with small effect sizes, allowing the calculation
of polygenic risk scores (PRS) based on hundreds of low effect
alleles. The largest schizophrenia GWAS to date identified 128
variants at 108 genomic loci (4). However, these risk SNPs still
only identify a very small percentage of risk, and the frequency of
risk-associated alleles typically differ by <2% between case and
control cohorts (59). The large majority of risk SNPs identified
through GWAS reside in non-coding regions, which suggests
that much of the identified genetic risk may be highlighting gene
regulatory mechanisms. However, it is important to note that
many such associated SNPs may have only reached significance
as a consequence of being in linkage disequilibrium (LD) with
truly causal SNPs, while conferring no risk-related functional
alteration on their own. Despite this, a number of studies have
confirmed that individual GWAS SNPs at key schizophrenia-
associated loci reside in regulatory regions that are active in the
CNS (60, 61), and that have functional consequences based on
SNP genotype (62, 63).
It has previously been assumed that genetic variants that
are associated with disease risk would be clustered at disease
relevant gene loci, or around genes with relevant tissue-specific
expression. However, it has been argued that enrichment of
GWAS signal at specific disease relevant loci is weak for many
complex traits and conditions (12). In the case of schizophrenia,
work by Loh et al. demonstrated that 71–100% of all 1Mb
windows in the human genome contain one or more identified
GWAS variant(s) which would influence schizophrenia risk (13).
However, within such blocks in the cortex, Bryois et al. found
that schizophrenia-associated SNPs were enriched in regions of
open chromatin (15). Such findings provide further evidence
consistent with a G× Emodel, in which our environment is likely
able to modulate our neurochemistry, with potential effects on
our risk for mental health conditions (16).
As stated, GWAS signal was found to be strongly enriched
in regions of chromatin that are active in disease-relevant cell
types. However, work by Boyle et al. demonstrated that, while
genes with brain-specific expression patterns were more strongly
enriched for schizophrenia-associated GWAS SNPs, SNPs within
or near to genes with broad and non-specific expression profiles
contributed more to the total schizophrenia heritability due to
their larger number (12). Boyle et al. also noted weak enrichment
for relevant functional ontologies associated with identified
schizophrenia risk loci, which would be consistent with results
from the Psychiatric Genomics Consortium (4).
Such findings have resulted in a hypothesized “omnigenic
model” of complex conditions such as schizophrenia, in which a
small number of variants have regulatory effects on core pathways
central to schizophrenia, while a much larger number of variants
influence expression of a peripheral gene set which can modify
the action of the core gene set. This model would support the
finding that variation affecting genes in core associated pathways
explains only a small fraction of schizophrenia heritability, while
the remaining heritability may be explained by many small
variations across all other expressed genes (4, 12).
Uncovering Functional Mechanisms of
GWAS Variants
Current research is beginning to integrate GWAS data with
expression and methylation quantitative trait loci (eQTLs,
meQTLs) to determine patterns of gene expression and altered
regulation that may contribute to schizophrenia biology (64–
67). Similar work is beginning to overlay GWAS data with
chromatin profiles in relevant cell types in order to identify
potential chromatin-modifying effects of GWAS SNPs.
Environmental stressors, such as childhood adversity,
have been associated with altered methylation across CNS-
expressed genes, such as FK506 binding protein 5 (FKBP5)
and glucocorticoid receptors, which are known regulators of
the stress response and have been associated with psychiatric
conditions such as depression and PTSD (42–44). Further,
methylation of the KIT ligand (KITLG) locus, which encodes the
ligand for the receptor tyrosine kinase, KIT, has been shown to
mediate the association between childhood trauma and cortisol
stress response, and has been highlighted as a region of interest
with regard to epigenetic programming of stress reactivity (68).
Multiple different types of early life trauma have been
demonstrated to alter methylation at the glucocorticoid receptor
in peripheral blood of individuals with diagnosed psychiatric
conditions (42). Those that had been exposed to sexual
abuse, physical abuse/neglect, and emotional abuse/neglect, had
significantly higher levels of methylation across multiple CpG
regions at the glucocorticoid receptor locus compared to those
without such exposures. Further, a dose-response relationship
was evident, in which exposure to multiple trauma types, or
increased trauma severity, was associated with higher levels of
methylation at this region (42). Methylation changes in response
to trauma can also be mediated in a genotype-dependent manner,
as in the case of FKBP5 (43).
Schizophrenia GWAS SNPs are known to significantly
overlap with eQTLs and meQTLs in the adult hippocampus,
frontal cortex, and the fetal brain (69–71), suggesting that
some associated variants may mediate risk by influencing gene
methylation, potentially in a differential manner in response to
environmental stimuli. Fetal brain meQTLs have been found
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to be enriched in functional elements and were similarly
demonstrated to be over-represented for schizophrenia GWAS
variants and at schizophrenia-associated genomic loci (69). The
majority of fetal brain meQTLs (83.46%) showed evidence of
functionality in at least one of the adult brain regions tested in
this study (pre-frontal cortex, striatum, and cerebellum), though
such shared fetal and adult meQTLs that were enriched at
schizophrenia-associated loci were found to have stronger effects
in the fetal brain than in the adult brain. The remaining subset of
fetal-specific meQTLs were also found to be enriched at genomic
loci that had previously been associated with schizophrenia
through GWAS (69). That many fetal meQTLs in the brain
are preserved in adulthood may suggest a mechanism through
which the effects of early environmental challenges can persist,
influencing epigenetic risk and neurodevelopment in ways
which may modulate the likelihood of experiencing psychiatric
conditions (64).
Similarly, ATAC-seq (Assay for Transposable Accessible
Chromatin) on post-mortem dorsolateral prefrontal cortex (DL-
PFC) samples from 135 adults with a diagnosis of schizophrenia
and 137 controls demonstrated that schizophrenia GWAS SNPs
were enriched in accessible chromatin regions in the brain, with
1.2% of the GWAS SNPs in DL-PFC ATAC-seq peaks accounting
for 8.55% of schizophrenia SNP heritability (15). ATAC-seq
peaks from fetal brains were also enriched for schizophrenia
association, demonstrating that such risk-related regulatory loci
are accessible, and thus likely active, during early development
(15). Taken together, such findings may provide a mechanism
through which neurodevelopmental risk factors, such as
maternal stress or immune activation, may have a lasting impact
on the developing and adult brain by affecting gene expression
through the modulation of methylation and chromatin
accessibility.
Insights and Complications in Using
Polygenic Risk Scores
Additional utility for the wealth of GWAS data has been
found in the generation of PRS. PRS use data on variants
across multiple associated loci in order to try to predict risk
for a particular condition based on combined SNP genotypes.
To date, multiple studies have demonstrated that increased
polygenic risk for schizophrenia is significantly associated
with increased odds ratios (OR) for schizophrenia-spectrum
diagnoses, such as schizophrenia, schizoaffective disorder, first
episode psychosis and psychosis not otherwise specified (4, 72,
73). The odds ratio is a measure of association between an
exposure and an outcome. In this instance, increased overall
genetic risk for schizophrenia is associated with a higher
likelihood of schizophrenia-spectrum diagnosis. Notably, the
landmark publication on recent schizophrenia genetics research
identifying 108 schizophrenia-associated loci demonstrated that
the highest polygenic risk scores in their analysis were associated
with an odds ratio for schizophrenia of 7.8–20.3 (4). However,
almost all studies on PRS and schizophrenia risk did not account
for the influence or interaction with other known risk factors,
such as early life stress. Further work has now begun examining
to which risk-related traits the PRS may predispose, and how
polygenic risk may interact with other such risk factors.
Higher schizophrenia PRS have been associated with
increased levels of anxiety in a non-clinical adolescent
population, but failed to demonstrate an association with
psychotic experiences (74–76). This may suggest that
schizophrenia risk in adolescence presents as, or contributes to,
known phenotypes that are associated with schizophrenia in
adulthood, such as anxiety or increased stress sensitivity. Higher
schizophrenia PRS have also been associated with reduced
hippocampal volume in FEP individuals and those classified as
having an “at risk mental state” (ARMS) (73), as well as with
multiple immune conditions (77), which provides supporting
evidence for immune system mechanisms in schizophrenia.
The interaction of schizophrenia GWAS SNPs with
environmental stressors, including early life complications
(ELCs) such as complications during pregnancy, labor, and
delivery, have further been shown to influence the effects of
schizophrenia PRS (17). Ursini et al. constructed schizophrenia
PRS using GWAS SNPs from meta-analyses of Psychiatric
Genomics Consortium (PGC) data sets (17). Odds ratios
for schizophrenia were calculated for each subset of PRS in
comparison to the lowest polygenic risk quintile, in individuals
with or without ELCs. For individuals in the highest polygenic
risk quintile without ELCs, no statistically significant change
in odds ratio for schizophrenia was observed. These findings
were validated in separate Italian and German case-control
cohorts, with the finding that five times more schizophrenia risk
was explained by an individual’s PRS in the presence of ELCs
compared to such scores in the absence of ELCs. This relationship
was seen for polygenic risk scores constructed using statistically
significant GWAS SNPs, and also for PRS constructed with SNPs
showing a trend toward genome-wide significance, but not for
other putatively associated SNPs. The authors suggested the
possibility that the high statistical significance of these SNPs
identified by GWAS in a heterogeneous group of case samples
may be due to their interaction with common environmental
risk factors, which, in combination, would confer a strong
effect on risk (17). Such work may in part explain the relatively
low penetrance of common schizophrenia risk variants when
assessed or inherited without the appropriate environmental
context through which they exert their influence on mental
health risk.
A study by Curtis further demonstrated that, while PRS
were significantly associated with schizophrenia in the Common
Mind Consortium data set, these measures were not robustly
associated with expression of any of the 16,423 individual genes
tested, nor with expression of specific schizophrenia-associated
gene sets (78). Curtis suggested that common variants may
instead be influencing indirect risk factors that may be far
removed from core biological pathways, such as increasing
risk for, or response to, schizophrenia-associated environmental
factors. Indeed, Ursini et al. found that PRS for schizophrenia
increased the likelihood of experiencing an ELC (17), and
further PRS have been shown to significantly predict risk for
multiple immune conditions (77). This could provide support
for the hypothesis that polygenic risk for schizophrenia may be
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identifying predisposition to other environmental risk factors
for this condition (78), such obstetric complications, or altered
immune function that may increase the likelihood of maternal
infection.
Schizophrenia Risk Is Likely to be Driven
by Environmental Challenge
Recent insights into the genomic underpinnings of schizophrenia
have been successful in more clearly elucidating the complex
polygenic architecture of this condition, and in providing support
for the biological targets of currently available pharmacological
treatments. However, schizophrenia GWAS signal is widely
distributed across the genome, and does not necessarily converge
on particular loci or novel molecular pathways (13). This
has hindered the identification of new targets for improved
pharmacological intervention. While PRS for schizophrenia have
for the most part shown reliable increases in risk with increased
genetic burden, emerging research in this area is beginning to
highlight roles for environmental interaction with genetic risk,
while raising the possibility that PRS may in part be predisposing
to other schizophrenia-associated risk factors (e.g., obstetric
complications) rather than the condition itself (17, 78). This
may suggest that research should target a better understanding
of these risk mechanisms, by which environmental stressors
modulate biological pathways to explain observed alterations in
schizophrenia.
EARLY LIFE STRESS AND
SCHIZOPHRENIA RISK
Polygenic risk scores in schizophrenia point toward a potential
for genetic risk to be mediated through environmental stress
(17, 78). This section examines the evidence for one of the most
significant and preventable risks for psychosis and schizophrenia
(18, 19), the experience of early life stress and trauma, the
mechanisms through which this may increase risk, and potential
treatment options.
The experience of trauma can be defined as a highly
stressful event that involves serious threat to one’s physical
wellbeing and to one’s sense of self, as well as overwhelming
one’s capacity for coping (79). The Diagnostic and Statistical
Manual of Mental Disorders 5th Edition (DSM-V) defines a
traumatic event as involving actual or perceived threat of death,
serious injury, or violence (80). Such experiences are likely to
involve intense feelings of fear and helplessness (81), though
these criteria are no longer required to define a traumatic
experience in the DSM-V. Further, traumatic experiences can
be encountered in a number of ways, including direct personal
exposure to trauma, witnessing another person’s experience of
trauma, or in indirect ways such as coping with the trauma
experience of a close associate, or repeatedly being exposed
to the consequences of traumatic events in a professional
role (such as emergency responders, or investigators of violent
crime).
It is important to note that the studies covered in this review
largely consider only experiences of direct personal trauma, and
of trauma that is of an interpersonal nature, for the most part
involving victimization. This includes experiences of multiple
types of abuse (emotional, physical, sexual) and neglect, as well as
experiences such as bullying. Other types of trauma experiences,
such as natural disasters or sudden, life-threatening illnesses,
were not included in this review. Further, the effects of exposure
to pre- or peri-natal stressors are not covered in this review, nor
are the effects of early stress thatmay be linked to poverty or other
social factors.
Early Life Stress as a Risk Factor for
Psychosis and Schizophrenia
Psychologically healthy individuals who report psychosis-like
experiences have been found to have higher incidences of
childhood trauma (24–26). Early experiences of trauma and
adversity are well known risk factors for mental illness,
with a World Health Organization (WHO) study of almost
52,000 individuals across 21 countries demonstrating that
childhood adversity accounted for 30% of all adult mental
health conditions (82). Similarly, a meta-analysis of studies
assessing the link between childhood adversity and psychosis
demonstrated that 78% of studies tested showed a positive
association between childhood adversity and psychosis, and that
33% of the population risk for psychosis could be attributed to
experiences of childhood adversity (18). A more recent study of
23,998 individuals examining the population attributable risk of
childhood adversity on psychosis demonstrated similar results,
finding 31% of psychosis cases to be attributable to early
adversity (19).
Individuals at clinical high risk (CHR) for psychosis typically
also report higher rates of childhood trauma. A meta-analysis of
six studies on ultra-high risk (UHR) populations demonstrated a
significant increase in exposure to childhood trauma (83). Loewy
et al. further demonstrated that exposure to trauma is typically
experienced in early life (before age 12) in clinical high risk
populations, and occurs prior to the onset of clinical high risk
symptoms (84).
Studies to assess the reliability of retrospective trauma
reporting in individuals experiencing psychosis demonstrated
that reports of trauma are consistent across time and are
not significantly affected by current mental health status (85).
Fisher et al. also demonstrated that retrospective trauma
reporting was consistent with independent clinical case notes
from abuse reports (85). However, a number of studies
have also reported that minimization and denial of trauma
is common in both case and control populations (86, 87),
with minimization and denial of trauma being significantly
increased in controls compared to individuals with psychosis
in a recent study by Church et al. Despite this, individuals
with experiences of psychosis still had significantly higher rates
of self-reported childhood trauma (61% of case individuals
reporting trauma, compared to 15% of controls) after correcting
for minimization and denial scores in this study (87). Indeed,
MacDonald et al. have suggested that current estimates of
the relationship between childhood trauma and psychiatric
conditions may be conservative due to the under-reporting
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of trauma experiences. The authors further suggest that
future studies investigating childhood trauma should measure
minimization and denial scores in order to account for such
biases (86).
While specific types of adverse experience have all been
shown to increase overall psychosis risk (18), it has further been
demonstrated that specific types of adversity show a correlation
with specific psychotic symptoms (21, 88). For example, Bentall
et al. demonstrated that childhood rape was associated with
a significantly increased risk of hearing voices, but did not
significantly alter risk of paranoia (21). On the other hand,
growing up in institutional care was significantly associated with
increased odds of experiencing paranoia, but did not significantly
alter risk of voice hearing. Some incidences of trauma were
also demonstrated to significantly increase the risk of both
voice hearing and paranoia, such as in the case of physical
abuse (21).
Furthermore, experience of trauma has been shown to have
a cumulative, dose-response effect on psychosis risk (18–21, 89).
For example, Shevlin et al. demonstrated that experiencing two or
more traumas (in childhood and/or adulthood) was predictive of
psychosis, with increased number of traumas also demonstrating
an additive effect on risk (20). Similarly, the 2012 meta-
analysis by Varese et al. highlighted that nine of the 10 studies
that tested for dose response in their analysis demonstrated
a positive correlation between increased number of adverse
events and increased risk of psychosis (18). This pattern also
remained when considering symptoms individually rather than
diagnosis. Bentall et al. demonstrated the dose response effect
of trauma for risk of paranoia and hearing voices, with a single
adverse experience significantly increasing the risk for both, and
additional traumatic experiences having an additive effect on
risk (21).
A recent meta-analysis of 29 studies into the effect of
childhood trauma on symptom severity in individuals with
psychosis demonstrated that childhood trauma was significantly
associated with increased severity of hallucinations and delusions
(90). On the other hand, childhood neglect was significantly
associated with increased negative symptoms and hallucinations
(90). Total trauma scores, as well as sexual abuse, were
significantly associated with increases in hallucinations, while
total trauma and sexual abuse (but not neglect) were associated
with increased delusions (90). Such work suggests that, as well
as predisposing to psychosis, individuals with experiences of
childhood trauma are also likely to experience more severe
psychotic symptoms.
Stress Sensitivity and Sensitization as a
Mechanism Mediating the Association of
Trauma and Psychosis
Stress sensitivity is known to be correlated with the incidence
of psychotic experiences (30). An individuals’ stress response
may be genetically influenced, but is also known to be modified
by previous experience, in which early life stress can sensitize
an individual to future stress (91, 92). Using World Health
Survey data across 39 countries and 176,934 individuals,
DeVylder et al. ranked individuals based on stress sensitivity
into groups from 2 to 10 (least to most stress sensitive).
Each increasing rank in stress sensitivity was associated with
incremental increases in the prevalence of psychotic experiences,
with stress sensitivity significantly increasing the odds of an
individual reporting psychotic experiences (30). This association
remained unchanged when carrying out the analysis either
including or excluding those with a self-reported diagnosis of
psychosis, and when separating the analyses for hallucinations
and delusions. Such data would suggest that increased stress
sensitivity is associated with increased risk of experiencing
psychotic symptoms; both in the general population and in those
with diagnosed psychotic conditions, and that this relationship
is shared throughout many countries and cultures across the
world (30).
As well as increasing risk, stress sensitivity has further
been associated with the intensity of psychotic experiences in
both case and control populations. For example, Reininghaus
et al. demonstrated that increased sensitivity to multiple
types of stressful situations was significantly associated
with intensity of psychotic experiences in FEP individuals,
ARMS individuals, and in healthy controls (31). When
comparing groups, increased event-, activity-, and area-stress
sensitivities were significantly associated with increased intensity
of psychotic experiences in FEP individuals compared to
controls.
In individuals with experiences of psychosis, exposure to
childhood trauma was correlated with increased emotional and
psychotic reactivity to small daily life stressors in adulthood,
suggesting that early stress can sensitize individuals to future
stress in a way that may modulate their risk for psychotic
experiences, and may modulate the intensity of such psychotic
experiences (32) (Figure 1). Supporting this finding, there is a
known dose-response relationship between increased childhood
adversity and more significant increases in daily life stress
sensitivity in adulthood (93). Such work suggests a process
of sensitization to stress, in which those exposed to early
adversity may be sensitized to react more strongly in future to
daily stressors. This sensitization process may then modulate
risk for experiencing psychosis, or in individuals already
experiencing psychosis, may contribute to increased severity of
these experiences.
Cristóbal-Narváez et al. have provided evidence of this
mechanism specifically in psychosis-like experiences, in a cohort
of non-clinical adolescents (92). In this study, experiences
of abuse and neglect were associated with psychotic-like and
paranoid experiences, while exposure to bullying was associated
only with psychotic-like experiences. Abuse, bullying, and neglect
were significantly associated with negative affect. All types of
childhood adversity tested were found to be associated with daily
life stress reactivity, and adversity of an interpersonal nature
(bullying, abuse, neglect, and loss) mediated the psychotic-
and paranoid-like response to day-to-day social and situational
stressors. In particular, individuals reporting higher exposure to
bullying were shown to experience significantly higher levels of
paranoia in response to social stress than those with lower rates
of bullying (92).
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FIGURE 1 | The effects of childhood trauma on stress sensitivity and psychosis risk. Exposure to childhood trauma has been shown to be strongly associated with
risk of experiencing psychosis. Such early adversity has also been demonstrated to increase stress sensitivity, both in non-clinical populations and in those
experiencing psychosis, which is known to increase both risk and intensity of psychotic experiences. In this model, experience of early trauma is predicted to increase
an individual’s baseline risk for psychosis, while predisposing them to react more strongly to future stressors. This would further amplify psychosis risk when faced with
later stressful experiences during adolescence or adulthood. Risk in this model can also be modulated by the individual’s genotype, and allele-specific responses to
environmental stressors, the effects of which are not shown in this diagram.
The Effects of Early Trauma on Brain
Structure and Function
Childhood adversity was found to be associated with changes
in brain structure and connectivity in non-clinical adolescent
and adult groups (91, 94, 95), with such physical changes
being shown to correlate with mental health-related traits that
were likely to sensitize the individual to future life stress (91,
94). The traumagenic neurodevelopmental model of psychosis
(Figure 2) posits that experiences of early life stress, combined
with genetic risk, have the potential to alter the trajectory of
brain development or neurochemistry in ways that may put an
individual at higher risk of experiencing psychosis in response to
future adversity (27, 29).
Studies have demonstrated the association between childhood
trauma and alterations in brain structure and connectivity
(95, 96). At present, a number of studies have further
demonstrated that these trauma-associated structural changes
result in increased stress sensitivity in adulthood (91, 94). For
example, Gorka et al. demonstrated that childhood adversity
was correlated with differences in hippocampal and medial
prefrontal cortex gray matter volume in a sample of non-clinical
individuals (91). Increasing childhood trauma scores were
significantly associated with decreased gray matter volume in
the left hippocampus and the medial prefrontal cortex (mPFC),
but showed no association with gray matter volume in the
right hippocampus or amygdala. Both childhood adversity and
decreased gray matter were also correlated with increased anxiety
in response to recent life stress. They further demonstrated that
the association between decreased hippocampal and mPFC gray
matter volume and increased anxiety in response to current stress
was significantly mediated by trauma exposure, suggesting that
early stress-induced alterations in brain structure can result in
increased stress sensitivity in adulthood (91).
Similar studies in adolescents by Herringa et al. have shown
that increased childhood maltreatment scores are predictive of
lower resting state functional connectivity (rs-FC) between the
hippocampus and subgenual cingulate in both male and female
adolescents, and of lower rs-FC between the amygdala and
subgenual cingulate in female adolescents (94). The effect of
childhood maltreatment on the connectivity of these regions
remained significant after correction for current life stress. Lower
amygdala- and hippocampus-subgenual cingulate connectivity,
as well as higher childhood maltreatment scores, was found to
be predictive of higher rates of internalizing symptoms (found in
depression and anxiety) in adolescents. In both male and female
adolescents, experience of childhood maltreatment predicted
lower total rs-FC, which in turn modulated the relationship
between childhood maltreatment and internalizing symptoms
(94). This work provides evidence for the hypothesis that
childhood trauma can modulate brain connectivity, resulting
in increased levels of internalizing symptoms in a non-
clinical adolescent population. Evidence was not found to
support reversal of this model (i.e., childhood trauma leads to
internalizing symptoms, which results in altered connectivity),
thereby suggesting that the effect of trauma on brain connectivity
increases internalizing behavior, rather than such behavior
affecting brain connectivity.
A recent review on this subject summarizes the evidence
suggesting specific effects of different childhood trauma types
on situation-relevant brain regions (97), such as alterations in
auditory and language processing regions in those who were
exposed to repeated verbal abuse (98, 99), and alterations in brain
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FIGURE 2 | The traumagenic neurodevelopmental model of psychosis. The
traumagenic neurodevelopmental model of psychosis suggests that the
interaction between an individual’s genotype and environment would influence
brain development in ways that could modulate psychosis risk in response to
future life stress. For example, childhood trauma may negatively impact a
child’s brain development, resulting in molecular or structural changes that
affect their response to adversity later in life. Experiences in adolescence and
adulthood can then either result in further increased risk, such as in the case of
chronic stress or further trauma experiences, or can reduce the individual’s
risk, in the case of receiving social support or appropriate treatment. The
combination of genotype, brain development, and adolescent/adult life
experiences can combine to influence the individual’s molecular and biological
response, as well as their behavioral response to future stress, which can in
turn interact with and impact their risk of experiencing psychosis. This figure is
reprinted, with alterations, from Heim et al. (28).
regions associated with processing sensory information from
the genitals in those who had experienced sexual trauma (100).
While such findings require replication, the authors suggest
an evolutionary hypothesis in which these CNS alterations in
response to trauma may be viewed as adaptive mechanisms to
facilitate survival in a threatening environment (97).
In line with the traumagenic neurodevelopmental model,
and adding another layer of complexity to this hypothesis, an
individual’s genotype has been shown to modulate the effects of
childhood trauma on changes in brain structure. For example,
Dannlowski et al. have demonstrated the effect of the oxytocin
receptor SNP, rs53576, on ventral striatum gray matter volume
in individuals with varying levels of childhood trauma (101).
Individuals who were homozygous for the G allele of rs53576
showedmarked decreases in ventral striatum gray matter volume
in response to childhood trauma, compared to A allele carriers,
who showed a small increase in gray matter volume at this region
in individuals with the highest trauma scores (101).
Similarly, Morey et al. demonstrated a significant interaction
between the genotype of the intergenic SNP, rs9373240, and
childhood trauma in influencing caudate volume in military
service members with experiences of childhood trauma (102).
In individuals with no childhood trauma, the homozygous T
rs9373240 genotype was not associated with caudate volume.
However, in those reporting experiences of early trauma,
rs9373240 TT individuals demonstrated significant association
with caudate volume in a dose-dependent manner. Those
reporting one type of trauma exposure showed significant
association of SNP genotype with caudate volume, while those
with experiences of two or more types of trauma showed
much more significant association of rs9373240 genotype
with caudate volume (102). The TT genotype of rs9373240
was significantly associated with increased caudate volume in
individuals with experiences of childhood trauma exposure, but
was not associated with PTSD diagnosis in this cohort.
Given the above studies, it is clear that early adversity is a
substantial and preventable risk factor for psychosis, and that
a significant proportion of individuals experiencing psychosis
are likely to have adapted both behaviorally and biologically
to respond differently to stress as a result of surviving early
threatening experiences. Recent research demonstrates that
increased stress sensitivity is a mechanism influencing psychosis
risk and symptom severity (30, 31), and as such is likely to offer
an additional route to intervention. For this reason, interventions
such as psychological therapy, which aim to understand the
impact of our life experiences on our behavior and current
difficulties, and assist the individual in coping with present life
stressors, have been gaining traction in the field of psychosis
research and treatment. The following section considers the
effects of stress and trauma on recovery, and the suitability of
psychological interventions for individuals with experiences of
psychosis.
TOWARD TRAUMA-INFORMED
TREATMENT OPTIONS FOR INDIVIDUALS
WITH PSYCHOSIS
Exposure to early life stress is known to influence symptom
severity and outcomes with regard to pharmacological treatment
with antipsychotic medications. The severity of early life trauma
has been shown to be significantly correlated with symptom
severity in individuals with psychosis (90). Similarly, those
with “treatment resistant” schizophrenia displayed significantly
higher levels of stressful life events, and scored more highly on
measures of emotional trauma and general trauma, than those
that respond to pharmacological treatment (40, 41). There is also
suggestive evidence that childhood trauma can affect response to
antipsychotic treatment in a genotype dependent manner. For
example, multiple SNPs across the matrix metallopeptidase 9
(MMP9) gene have been implicated in antipsychotic treatment
response, as measured by percentage change in Positive and
Negative Symptoms Scale score (PANSS) (103). McGregor et al.
found that the PANSS score change associated with SNP alleles
in MMP9 was modulated by exposure to childhood trauma.
In particular, homozygotes for the A allele of rs13925 without
trauma presented as significant responders to antipsychotic
treatment, with a 10.5% reduction in PANSS scores compared
to AG or GG individuals. However, individuals with the AA
genotype that had experienced early life stress presented as non-
responders to treatment, with an increase of 1.67% on the PANSS
scale (103). This finding has also been demonstrated in other
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mental health conditions, with early trauma exposure predicting
poor response to treatment and longer time to recovery in
individuals with major depressive disorder (104, 105). As such,
current pharmacological treatment for individuals with psychosis
may risk leaving traumatized individuals with an untreated and
highly stressful environmental component, which is likely to
continue to negatively impact both their neurochemistry and
recovery. Complicating this matter, the experience of psychosis
itself, and coercive elements of treatment such as involuntary
hospitalization, have repeatedly been shown to induce trauma
symptoms in up to two thirds of individuals experiencing
psychosis, resulting in clinical PTSD in one in three such
individuals (33–36).
Efforts to implement trauma screening in individuals
with psychosis revealed that PTSD is drastically under-
diagnosed in such populations (106). In a group of 2,608
individuals with a diagnosed psychotic condition, 0.5% had
a previously identified PTSD diagnosis. After implementing
trauma screening, this number increased to 16%, a striking
32-fold increase, demonstrating that 96.9% of PTSD cases in
individuals with psychosis in this study had previously gone
unreported and untreated.
Psychosis and Treatment as Traumatic
Experiences
A large proportion of individuals with experiences of psychosis
go on to suffer clinical PTSD, or PTSD-like trauma symptoms
from this experience, the risk for which is modulated by previous
experience of childhood trauma (38). Studies have demonstrated
that 66–69% of individuals meet the symptom criteria for PTSD
with regard to psychosis- and treatment-related trauma, and 30–
39%meet the full criteria for post-psychosis PTSD diagnosis (33–
36). Exposure to childhood trauma has been shown to increase
risk of experiencing post-psychosis trauma by 27-fold (38). Such
work clearly demonstrates that experiences of childhood trauma
not only predispose to experiences of psychosis, but are also likely
to hinder recovery from psychotic episodes by leaving individuals
vulnerable to experiencing post-psychosis trauma (Figure 3).
Further work with individuals that had experienced either a
single episode, or multiple episodes, of psychosis also yielded
similar results (34). In these studies, up to half of first episode and
multiple episode individuals met the DSM-IV criteria for having
experienced a traumatic event with regard to their experience of
psychosis (33, 34). Similarly, almost a third of first episode and
over a quarter of multiple episode individuals met the DSM-IV
criteria for having experienced trauma in relation to the mental
health treatment they received (33, 34).
A study of 395 individuals with a range of psychotic disorders
found 69% of individuals reporting that one or more of their
hospitalizations had been “traumatic or extremely distressing”
(39). Of the individuals in this study reporting treatment-related
trauma, the most frequently reported traumatic experiences were
involuntary hospitalization (reported by 62%), being placed in
physical restraints (40%), and being forcibly medicated (37%).
Similarly, 73% of individuals reporting treatment-related trauma
also reported feelings of intense helplessness, fear, and horror,
with 42% believing that they could be seriously harmed or
killed during treatment. Indeed, Paksarian et al. found that
39% of individuals reporting treatment-related distress met
the DSM-IV criteria for having experienced a traumatic event
(39).
Such studies would advocate for psychological therapy
interventions, and particularly trauma-informed interventions,
in supporting both those with psychosis influenced by prior
trauma, and those in recovery from psychosis who may be prone
to ongoing mental health difficulties or at risk of relapse due
to lingering trauma symptoms from the experience of psychosis
itself, and from any traumatic treatment-related events.
Psychological Therapies for Individuals
Experiencing Psychosis
Research into the utility of psychological interventions in
psychosis have lagged behind that of other mental health
conditions, such as depression and anxiety, likely due in part to
the long-held view that psychosis and schizophrenia are largely
biological conditions, or that individuals experiencing psychosis
may struggle to fully engage with psychological therapy due to
difficulties presented by ongoing symptoms (107). However, new
research is beginning to demonstrate the safety and utility of
psychological therapy for experiences of psychosis, particularly in
the case of trauma-informed therapy and adaptations of cognitive
behavioral therapy for psychosis.
Eye movement desensitization and reprocessing (EMDR), a
form of therapy typically used to treat trauma and PTSD, has been
shown to be safe and effective in significantly reducing trauma
symptoms in individuals with diagnoses of concurrent psychosis
and PTSD (48–50).
An assessment of the potential re-traumatizing effects of
psychological intervention for individuals with trauma and
psychosis compared symptom exacerbation, re-victimization,
and adverse events in a single-blind randomized control trial
comparing 108 individuals receiving trauma-focused treatment
(TFT) with 47 individuals on a waiting list receiving treatment
as usual (TAU) (49). In this study, TAU was administered in the
form of multi-disciplinary care from the individual’s community
mental health team, typically involving antipsychotic medication,
with further treatment and supportive counseling from multiple
members of this team. In the treatment arm, 53 of the participants
received prolonged exposure (PE) therapy, and 55 received
EMDR. This treatment was delivered over the course of 10
weeks, in the form of 8 weekly sessions lasting 90min each. As
no significant difference in the outcomes was found between
the PE and EMDR groups, the data was pooled to compare
trauma-focused treatments vs. the waiting list condition. When
comparing baseline to the post-treatment time point, those
in the waiting list condition had significantly higher rates of
self-reported PTSD symptom exacerbation compared to those
receiving TFT, though this difference became non-significant at
6 months follow up. Similarly, those in the waiting list condition
had significantly higher levels of general symptom exacerbation,
and showed a trend toward reporting increased paranoid ideation
post-treatment compared to those receiving TFT. No significant
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FIGURE 3 | The proposed effects of post-psychosis trauma on relapse risk. Up to two thirds of individuals have been shown to experience post-psychosis trauma,
the risk for which is significantly increased by exposure to prior trauma. It is likely that lingering post-psychosis trauma symptoms, if left untreated, would hinder an
individual’s ability to recover from this experience, and to maintain recovery when faced with later stressors. In this model, childhood trauma would significant raise an
individual’s baseline psychosis risk, while predisposing them to experience post-psychosis trauma. After an experience of psychosis, in this example triggered by a
stressor, the individual’s psychosis risk is further amplified by untreated post-psychosis trauma symptoms. This may result in a lower threshold for experiencing further
episodes of psychosis in response to future stress, potentially also with the capacity for increased symptom frequency or intensity in later episodes.
difference was found between the groups for clinician rated PTSD
symptoms or depressive symptoms at the post-treatment time
point. Those in the TFT group were found to be significantly
less likely to experience adverse events during treatment and
follow up, with a relative risk reduction of 27.9 and 34.6% post-
treatment and at 6 months follow up, respectively. Similarly,
the rates of re-victimization were significantly lower in the TFT
group compared to waiting list at 6 months follow up, but not
at the post-treatment time point (49). This work demonstrates
that trauma-focused therapy is safe for use with individuals
experiencing concurrent psychosis and PTSD, and is unlikely to
cause distressing side effects or symptom exacerbation.
In a single-blind randomized control trial, 66 participants
with FEP were randomly assigned to receive TAU or cognitive
recovery intervention (CRI), a treatment aimed to reduce
experiences of post-psychosis trauma (51). At 6 months follow
up, those that had received CRI presented with significantly lower
levels of post-psychosis trauma, with over two thirds reporting
substantial improvement in trauma symptoms, compared to
those receiving TAU, of which one third reported improvement.
In particular, those reporting higher levels of pre-psychosis
trauma benefited most from CRI (51), suggesting that individuals
with prior trauma experiences may stand to benefit significantly
from trauma-informed support. The authors note that failing
to provide early cognitive therapy-based intervention to those
experiencing first episode psychosis may put more than twice
as many individuals at risk of lingering or worsening trauma
symptoms following a psychotic episode (51).
In the UK, psychological therapy (particularly CBT) has been
recommended as a frontline treatment for individuals both at
risk of experiencing psychosis, and those experiencing psychosis
(54). A recent single-blind randomized control trial involving
75 individuals compared the effects of antipsychotic medication
alone, CBT alone, and a combination of antipsychotic treatment
plus CBT (53). All treatment arms were found to significantly
reduce symptoms, with total PANSS scores being significantly
decreased in the combined treatment group compared to
the CBT group alone. Reduction in PANSS scores was not
significantly different between the treatment alone groups, or the
antipsychotic and combined treatment groups. Morrison et al.
found no difference in adverse events between the three groups,
but reported fewer side effects in the CBT alone group (53).
Such studies demonstrate the utility and feasibility of CBT as a
treatment option for those with experiences of psychosis.
Similarly, an earlier single blind randomized control study
in individuals not taking antipsychotic medications compared
74 individuals randomized to TAU or to TAU plus CBT (52).
In this instance, TAU referred to regular and comprehensive
care co-ordination and psychosocial interventions, with regular
monitoring through PANSS assessment, as well as options
for crisis management and family interventions. This trial
further demonstrated the ability of CBT to significantly reduce
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psychiatric symptoms (as measured by PANSS score) in those
receiving this intervention, compared to those receiving TAU,
with the authors reporting an effect size comparable to those
identified in meta-analyses of psychiatric medication efficacy.
Change in symptoms included significant improvements in total
PANSS score and scores for positive symptoms, as well as
improvements in some dimensions of delusional beliefs, voice
hearing, and social functioning. However, cognitive therapy
intervention was not found to have an effect on negative
symptoms in this study (52).
An additional trial involving 385 individuals receiving CBT
demonstrated that this intervention was effective in bringing
about significant and sustainable improvements in delusional
beliefs, voice hearing, anxiety, depression, and quality of life,
which were maintained at 6 months follow up compared to pre-
therapy baselines (57). Similarly, a meta-analysis of randomized
control trials comparing CBT vs. TAU in the treatment of
delusions demonstrated that cognitive therapy intervention
significantly improved delusional beliefs, an effect which was
maintained to an average follow up time of 47 weeks across the
studies (56). However, CBT was not found to be significantly
different in terms of effectiveness in comparison to other
psychological interventions. A further meta-analysis of 12 studies
found that CBT resulted in long-term beneficial changes in
positive symptoms in individuals whose condition had previously
been identified as medication-resistant (55). As well as evidence
demonstrating the effectiveness of CBT in improving positive
symptoms, a recent meta-analysis by Lutgens et al. also provided
evidence for CBT and a number of psychosocial interventions
in improving negative symptoms of psychosis (108). Lutgens
et al. assessed 95 studies reporting negative symptom outcomes
in order to determine the effectiveness of CBT and psychosocial
interventions on these symptoms (108). Of the 95 studies, 26
studies assessed the efficacy of CBT. In this analysis, CBT was
found to be an effective intervention for the treatment of negative
symptoms compared to TAU in 59% of studies. However, in
12 studies that used an active control, no significant difference
was found between groups. This would suggest that other active
psychosocial interventions may also be beneficial for individuals
experiencing negative symptoms of psychosis. Indeed, Lutgens
et al. also found evidence to support the utility of skills-,
exercise-, and music-based interventions in the treatment of
these symptoms (108).
Despite a number of positive meta-analyses such as those
above (55, 56, 58, 109), debate around the efficacy of
psychological therapy for psychosis continues (110). Some
studies have failed to find beneficial effects for CBT in the
treatment of psychosis (111), or found only small effects
(112), while others have reported variable outcomes which are
influenced by other factors, such as the relationship between the
client and therapist (113). It is also important to understand
the potential barriers that may prevent an individual from
accessing or benefiting from such interventions. For example,
a recent study by Hazell et al. found that both clients and
clinicians felt that ongoing psychotic symptoms might be one
of a number of challenges in implementing such interventions,
along with additional practical barriers, such as lack of resources
within mental health services (107). Further research in this
area will be necessary to improve access to, and utility
of, psychological therapy for those experiencing psychosis.
Additional work by Hazell et al. has suggested that symptom-
specific treatment may be one route to overcoming the identified
barriers (114).
With regard to randomized control trials, it has been
suggested that the variability inherent in tailoring psychological
therapy to the needs of each client may make such interventions
difficult to assess in a trial setting, leading to overgeneralized
criteria that do not accurately assess the efficacy of therapy in
achieving the client’s individual goals (115). On this subject, some
have criticized the use of outcome measurements which are often
based on overall symptom scales, with the assertion that the most
appropriate uses for CBT are in, for example, targeting specific
dimensions of an individual’s delusional beliefs, aiming to reduce
distress, and aiming to improve the individual’s ability to cope
with such experiences (116). Birchwood et al. suggested that
the intricacies of such changes were unlikely to be captured by
generalized symptom measurements, despite the fact that they
may represent significant benefits for the client. In support of
this, qualitative research into service user priorities identified that
managing stress and anxiety were among the most commonly
endorsed immediate treatment priorities for those experiencing
psychosis, with improved coping and emotional wellbeing
identified as top long-term treatment priorities (117). Similarly,
research addressing personal experiences of CBT demonstrated
that coping strategies were among the most commonly cited
key components of CBT for those receiving this intervention
for psychosis (118). This would suggest that improved ability
to cope with stressors is considered to be among the most
useful and valuable benefits by clients, regardless of actual change
in symptom frequency or severity. However, measures of such
benefits are often not included when assessing the efficacy of
therapy in clinical trials.
Despite such debate (the remainder of which is beyond
the scope of this review), research is ongoing with the
aim of resolving such questions, and further establishing the
effectiveness of CBT for individuals with psychosis. Preliminary
research is also being carried out to assess the suitability of a
number of other therapeutic modalities for use with individuals
experiencing psychosis, including Cognitive Analytic Therapy
(CAT) (119, 120), Compassion Focused Therapy (CFT) (121,
122), and others, with the hope of providing additional choices
with regard to evidence-based treatment options for those
seeking psychological therapy-based care.
LIMITATIONS
This work has a number of limitations that are of note.
Firstly, this review aimed to cover a very wide range of topics
from molecular biology to psychological therapy. Given the
breadth of this article, there was insufficient space to present
and deeply discuss the full range of supporting and opposing
evidence for each topic. It did not systematically review the
literature relating to control trials of psychological therapy
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for psychosis, nor did it evaluate the quality of evidence in
the studies reported. While the authors endeavored to fairly
and accurately represent the available literature, this lack of
systematic procedure means that the introduction of bias cannot
be ruled out. Secondly, this review covers only very specific and
extreme experiences of early life stress and trauma. As discussed
above, the studies referenced in this review focus almost
exclusively on direct personal experiences of victimization,
centered largely around interpersonal abuse and violence. It is
important in this case to note that additional non- victimization-
based, or non-direct experiences, such as sudden and life-
threatening illness, or witnessing another person’s experience
of trauma, may also constitute traumatic experiences and
have the potential to contribute to future mental health risk.
Similarly, the effects of pre- and peri-natal stressors, such as
maternal stress, were not included, nor were additional factors
which may contribute to early life stress and psychosis risk,
such as low socioeconomic status. While there was not scope
in this review to do so, the authors believe it is also of
import to acknowledge the intersecting effects of numerous
personal and social categorizations (e.g., race, sexuality, gender
identity, socioeconomic status) in influencing one’s likelihood
of experiencing discrimination, disadvantage, or victimization
that may result in trauma or repeated exposure to stress,
thereby contributing to risk of developing related psychiatric
symptoms.
SUMMARY AND CONCLUSIONS
Recent advances in the field of schizophrenia genetics have
demonstrated the highly polygenic nature of this condition,
with many common risk variants of low effect size spread
widely across the non-coding genome (4, 13). That a significant
number of identified risk variants fall within proposed regulatory
regions (12, 15) would suggest that risk for schizophrenia or
psychosis is likely to be modulated by environmental stressors
in a genotype-dependent manner. Indeed, a significant number
of schizophrenia GWAS SNPs have been shown to act as eQTLs
or meQTLs, influencing gene expression or methylation in the
human brain (69–71).
Childhood adversity is one of the largest preventable risk
factors for experiencing psychosis (18, 19), and has been shown to
significantly alter methylation across key stress response gene loci
in humans (42–44). Exposure to childhood trauma has also been
associated with alterations in brain structure and connectivity
(91, 94, 95), with evidence to suggest that the effects of childhood
trauma on brain structure can be influenced by genotype (101,
FIGURE 4 | The potential effects of psychological therapy on post-psychosis trauma and stress impact. Recent research into psychological therapy for psychosis is
beginning to demonstrate the ability of such interventions to improve both psychosis symptoms as well as secondary issues in those experiencing psychosis, such as
anxiety and depression. Similarly, psychological therapy is able to reduce distress associated with psychosis symptoms, and improves the individual’s ability to cope
with stressors. This diagram outlines one potential risk trajectory that may be associated with effective psychological therapy intervention. In this example, the
individual has experienced early life trauma and post-psychosis trauma, which resulted in very high risk for experiencing relapse in response to further stress. If this
individual receives successful therapy after their first psychotic episode, this could decrease risk of further episodes by working to resolve both early and recent
trauma experiences, and by providing the individual with an improved ability to cope with stress. As can be seen in this figure, subsequent stress following therapy
may have a smaller effect on risk due to the individual’s improved capacity for coping. While not shown here, psychological therapy intervention may also be provided
as a preventative measure to those at high risk for psychosis. Such intervention would similarly aim to improve coping and reduce the effect of stress, with the hope of
preventing a psychotic episode in the future.
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102). Such alterations in brain structure have been shown to
be associated with increased stress reactivity (91), high levels of
which is a known risk factor for psychosis (30), and has been
shown to be associated with increased symptom severity in those
experiencing psychosis or psychosis-like symptoms (32, 92). This
traumagenic neurodevelopmental model of psychosis suggests
that exposure to early life trauma can alter the trajectories of
neurodevelopment and neurochemistry to influence response to
future life stress in ways that would increase risk of experiencing
psychosis (27, 29), and increase symptom severity in those
with this condition (Figure 1). Given that over two thirds of
people experience post-psychosis trauma symptoms (33, 34)—
the likelihood of which is vastly increased by prior trauma
exposure (38)—it is likely that lingering trauma symptoms and
heightened stress sensitivity (32) will negatively impact the
individual’s ability to achieve or maintain recovery in the face
of day-to-day or future stressors (Figure 3). Treating only with
pharmacological interventions is unlikely to resolve such distress,
or equip the individual with useful coping strategies, and as
such, repeated experiences of stress will continue to act on the
individual’s mental health in a G× E manner.
Thinking in this G × E way about psychosis would advocate
for the role of psychological therapies or other social support
as ways to help a person cope with or resolve the stress
in their life, that may be preventing them from achieving
or maintaining recovery (Figure 4). Recent studies into the
utility and effectiveness of psychological therapy for psychosis
have demonstrated that trauma-informed therapies are safe and
effective for use with such clients (48–50), and can reduce
rates of re-victimization and post-psychosis trauma (49, 51).
Similarly, meta-analyses assessing the effectiveness of CBT for
psychosis have demonstrated that such interventions can provide
sustainable improvements in positive symptoms (56, 58, 109),
including in individuals that had previously been classified as
“treatment resistant” (55).
A wealth of research, both biological and psychological,
has demonstrated the effects of stressful life experiences on
our epigenetics and subsequent risk of developing a mental
health condition, though research into the epigenetic effects
of positive experiences and their effect on mental health are
less studied. Given the genetic data showing that common
schizophrenia risk falls largely in regulatory regions which
are likely to be responsive to environmental challenge or
change, support that positively affects an individual’s day-to-day
environment or stress levels may be a feasible route to positive
and therapeutic epigenetic change. Indeed, preliminary studies
into the biological effects of therapy have demonstrated that
psychological interventions can modulate biological mechanisms
relevant to mental health, such as altering methylation over
key CNS genes (45–47, 123), and modulating connectivity
between brain regions that are relevant to psychosis in
ways which correlate with clinical improvement in symptoms
(124, 125). While further research is needed to address
a number of questions and criticisms around the use of
psychological therapy for psychosis, such interventions provide
hope, particularly for those who find antipsychotic treatment
unhelpful or intolerable, and for those with experiences of
trauma, the ongoing effects of which are unlikely to have been
adequately appreciated or addressed in regard to their mental
health.
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